EVP, Chief Development Officer Poulton Stuart sold $22,317 worth of shares (3,548 units at $6.29), decreasing direct ownership by 11% to 27,414 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

KPTI· Karyopharm Therapeutics Inc.

Health Care

Original source

EVP, Chief Development Officer Poulton Stuart sold $22,317 worth of shares (3,548 units at $6.29), decreasing direct ownership by 11% to 27,414 units (SEC Form 4) | Quantisnow